Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical ResearchfiledCriticalRIKEN Institute of Physical and Chemical Research
Priority to JP14488677ApriorityCriticalpatent/JPS5387373A/en
Publication of JPS5387373ApublicationCriticalpatent/JPS5387373A/en
Publication of JPS5512030B2publicationCriticalpatent/JPS5512030B2/ja
PURPOSE: To prepare N,N,-bis-(2,-tetrahydrofuran)-5-fluorouracil useful as a carcinostatic agent and its intermediate, in high yield, by reacting bis(tri-lower alkyltin)5-fluorouracil(novel compound)with 2-halo-tetrahydroguran.
COPYRIGHT: (C)1978,JPO&Japio
JP14488677A1977-12-021977-12-02Preparation of pyrimidine-type nucleoside
GrantedJPS5387373A
(en)